Decision-Support Tool for Alzheimer's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a shared decision-making support tool to assist doctors in discussing blood tests for Alzheimer's Disease with patients. The tool aims to enhance collaborative decision-making and information sharing between doctors and patients. Doctors will receive training to use the tool, and their interactions with patients will be compared to those who do not use it to assess its impact. Individuals aged 50 or older, living independently, and without a cognitive impairment diagnosis may be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to contribute to improving doctor-patient communication and decision-making.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this decision-support tool is safe for use in clinical settings?
Research has shown that the shared decision-making support tool, designed to assist doctors and patients in discussing Alzheimer's tests, is safe. This tool aims to enhance collaborative decision-making between doctors and patients. Since it does not involve medication or medical procedures, there are no concerns about physical side effects or adverse reactions.
Other studies have used similar tools for healthcare decisions, reporting no harm or safety issues. The primary goal of this tool is to clarify and improve conversations, not to alter medical treatments directly. Participants can therefore feel assured that using this tool poses no health risks.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a new way to support decision-making for Alzheimer's disease. Unlike current treatments that focus primarily on medications to manage symptoms, this trial examines a tool designed to enhance the interactions between doctors and patients. The decision-support tool is unique because it aims to improve how primary care physicians (PCPs) engage with patients during clinical encounters, potentially leading to more personalized and effective care plans. By simulating clinical interactions and providing targeted training, the tool could empower physicians to better address the complex needs of individuals with Alzheimer's, ultimately improving patient outcomes.
What evidence suggests that this decision-support tool is effective for improving shared decision-making in Alzheimer's Disease care?
Research has shown that tools for shared decision-making engage patients more deeply and increase their satisfaction with healthcare. These tools enhance communication between patients and healthcare providers, simplifying the understanding of options and facilitating informed choices. This trial will evaluate the shared decision-making support tool through simulated clinical encounters. In Alzheimer's care, these tools assist patients and caregivers in managing complex information. This approach can lead to better outcomes by reducing confusion and boosting confidence in decision-making. Overall, shared decision-making tools are valuable in supporting patients, especially in managing conditions like Alzheimer's disease.678910
Who Is on the Research Team?
Fred Ketchum, M.D., Ph.D.
Principal Investigator
University of Wisconsin, Madison
Are You a Good Fit for This Trial?
This trial is for adults visiting primary care who are considering blood tests to check for signs of Alzheimer's disease or memory loss. There are no specific inclusion or exclusion criteria listed.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Simulation 1
Assess the usability and acceptability of the decision-support tool through direct observation and surveys of PCPs in high-fidelity simulations
Simulation 2
Compare the effect of the decision-support tool on shared decision-making in high-fidelity simulated clinical encounters
Follow-up
Participants are monitored for safety and effectiveness after simulations
What Are the Treatments Tested in This Trial?
Interventions
- Shared decision-making support tool
Trial Overview
The study is testing a new decision-support tool that helps doctors and patients talk about blood biomarker testing for Alzheimer's in the clinic. Some doctors will use the tool, while others won't, to see if it improves shared decision-making.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
In Simulation 1, 15 PCPs will complete simulated clinical encounters with standardized patients after completing trainings on how to use the decision-support tool. In Simulation 2, a different group of 3-5 PCPs will see patients during simulated clinical encounters without using the decision-support too for the first half. In the second half, these PCPs will complete trainings on how to use the tool and then see the second half of the participants using the tool.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
Citations
Shared decision-making in dementia: A review of patient ...
Results indicated that not all persons with dementia are excluded from participating in the decision-making process, but there is a broad spectrum of what ...
FAIR Health Launches Alzheimer's Disease Shared ...
FAIR Health (FH) has launched a new shared decision-making tool for Alzheimer's disease that features clinical information for self-care ...
3.
healthsystemsevidence.org
healthsystemsevidence.org/articles/686300d030d17d002fd01e31-digital-decision-aids-to-support-decision-making-in-palliative-and-end-of-life-dementia-care-systematic-review-and-meta-analysis&source=latest_contentDigital decision aids to support decision-making in ...
Internet-based decision aids offer a feasible and acceptable approach to support the shared decision-making between patients, families, and clinicians.
Shared Decision Making and How It Impacts the Patient ...
Shared Decision Making (SDM) supports patient centered care and improves patient outcomes and satisfaction.
Intervention to Improve Shared Decision Making Among ...
five shared decision-making tools dealing with difficult decisions often faced by seniors with dementia and their caregivers.
6.
jpreventionalzheimer.com
jpreventionalzheimer.com/8501-time-saved-calculations-to-improve-decision-making-in-progressive-disease-studies.html“TIME SAVED” CALCULATIONS TO IMPROVE DECISION- ...
Combining multiple estimates of time saved across clinical outcomes measuring different domains can improve power for detecting disease ...
7.
researchgate.net
researchgate.net/publication/358220107_Designing_a_clinical_decision_support_system_for_Alzheimer's_diagnosis_on_OASIS-3_data_setDesigning a clinical decision support system for ...
In this paper, we propose a clinical decision support system (CDSS) We also used person disjoint subsets of the data to avoid reporting biased performance of ...
Project Details
Pilot analyses identified N=30,523 AD/ADRD patients with over 2.7 million patient/caregiver portal messages and 108,709 healthcare providers. This study will ...
Improving Informed Decision Making Through Real-World ...
The objective of this research is to generate real-world evidence on the treatment burden and safety of the monoclonal antibody therapy for Alzheimer's Disease ...
Lifestyle Interventions for the Treatment of EOAD Study ( ...
This data safety monitoring plan was developed based on prior studies using similar types of cognitive training (including BrainHQ) and Tai Chi exercises,
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.